PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Press/Media: Press / Media

Period2018 Oct 2 → 2020 Sep 12

Media coverage

2

Media coverage